Scroll Top
7005 Taschereau Boulevard, suite 265, Brossard, QC J4Z 1A7, Canada

Latest Press Releases

  • 2024-05-21, DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement – Learn More
  • 2024-05-09, DIAGNOS Announces Closing of First Tranche of Private Placement – Learn More
  • 2024-05-06, DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024 – Learn More
  • 2024-04-16, DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification – Learn More
  • 2024-04-09, DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11- Learn More
  • 2024-04-03, DIAGNOS Announces Grant of Stock Options – Learn More
  • 2024-04-02, DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors – Learn More
  • 2024-03-22, DIAGNOS Announces Closing of Second and Final Tranche of Private Placement – Learn More
  • 2024-03-04, DIAGNOS Announces Grant of Stock Options – Learn More
  • 2024-02-29, DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors – Learn More
  • 2024-02-27, DIAGNOS Announces Closing of First Tranche of Private Placement – Learn More
  • 2024-02-23, DIAGNOS Announces Change in One Insider Ownership – Learn More
  • 2024-02-21, DIAGNOS recognized as a Top TSX Venture Exchange Company – Learn More
  • 2024-01-16, DIAGNOS Appoints New Chief Operating Officer – Learn More
  • 2023-12-11, DIAGNOS Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica, a Global Leader in Vision Care – Learn More
  • 2023-12-04, DIAGNOS Announces Closing of Private Placement – Learn More
  • 2023-10-05, DIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & Endocrinology – Learn More
  • 2023-05-18, DIAGNOS Announces Closing of Private Placement and Exercise of Stock Warrants – Learn More
  • 2023-05-17, DIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS” – Learn More
  • 2023-02-14, DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts – Learn More
  • 2023-02-14, DIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023 – Learn More
  • 2023-02-10, DIAGNOS Announces Grant of Stock Options – Learn More
  • 2023-01-31, DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Tools in Quebec Hospitals – Download PDF
  • 2023-01-13, DIAGNOS Announces Closing of Private Placement – Download PDF
  • 2022-12-15, DIAGNOS Provides Additional Information to the Closing of Private Placement – Download PDF
  • 2022-12-12, DIAGNOS Announces Closing of Private Placement – Download PDF
  • 2022-11-25, DIAGNOS Announces Closing of Private Placement – Download PDF
  • 2022-10-27, DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology – Download PDF
  • 2022-09-01, DIAGNOS Announces Closing of Private Placement – Download PDF
  • 2022-08-18, DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems – Download PDF
  • 2022-07-27, DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics – Download PDF
  • 2022-06-23, DIAGNOS Announces the Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance – Download PDF
  • 2022-06-07, DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group – Download PDF
  • 2022-05-26, DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening – Download PDF
  • 2022-05-10, DIAGNOS Announces a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico – Download PDF
  • 2022-04-26, DIAGNOS Announces the Extension of its Contract with Novo Nordisk for the Follow-up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio – Download PDF
  • 2022-03-28, DIAGNOS Announces Closing of Private Placement and New Marketing Director – Download PDF
  • 2022-03-15, CAN Health Network and Quebec-Based DIAGNOS Announce Life-Changing Diabetic Retinopathy Screening Program Partnership – Download PDF
  • 2022-03-01, DIAGNOS Announces Closing of Private Placement – Download PDF
  • 2022-02-10, DIAGNOS Successfully Completes ISO / MDSAP Audit – Download PDF
  • 2022-01-26, DIAGNOS Provides Corporate Update for 2021 and Outlook for 2022 – Download PDF
  • 2021-12-15, DIAGNOS will be Attending in San Francisco during the J.P. Morgan Health Care Conference Week to be held from January 10th to 13th, 2022 – Download PDF
  • 2021-11-23, DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE – Download PDF
  • 2021-10-28, DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA – Download PDF
  • 2021-09-24, DIAGNOS to be Featured on CEO Clips on the BNN Bloomberg Channel – Download PDF
  • 2021-09-16, DIAGNOS Announces a Multi-Year Contract with Juarez Health & Medical Tourism Cluster – Download PDF
  • 2021-09-14, DIAGNOS Announces a 3-Year Contract with Cielo Vista Eye Clinic in Mexico – Download PDF
  • 2021-09-02, DIAGNOS Announces a Three-Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer’s Disease Test – Download PDF
  • 2021-08-17, DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders – Download PDF
  • 2021-08-16, DIAGNOS signs Memorandum of Understanding with Essilor International – Download PDF
  • 2021-07-28, DIAGNOS Announces a Pilot with Opticalia in Spain – Download PDF
  • 2021-07-22, DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia – Download PDF
  • 2021-07-20, DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE – Download PDF
  • 2021-06-15, DIAGNOS Announces a Pilot with Hospital Oftalmológico Buena Vista Sinaloa – Download PDF
  • 2021-06-09, IRIS, a New Look Vision Group Inc. company, teams up with DIAGNOS in a multi-year agreement to implement Artificial Intelligence technology with support from the INVEST-AI Program – Download PDF

Our press releases are also available on SEDAR

Have any questions or inquiries?